Medistim ASA (Norway) Management Evaluation
| MEDI Stock | NOK 260.00 3.00 1.14% |
Medistim ASA employs about 116 people. The company is managed by 10 executives with a total tenure of roughly 271 years, averaging almost 27.0 years of service per executive, having 11.6 employees per reported executive. Inspection of Medistim ASA's management performance can provide insight into the company performance.
| Thomas Jakobsen Insider Chief Officer |
| Ole Robsrud Insider CEO AS |
Medistim |
Medistim ASA Management Team Effectiveness
The company has return on total asset (ROA) of 0.1953 % which means that it generated a profit of $0.1953 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3112 %, meaning that it generated $0.3112 on every $100 dollars invested by stockholders. Medistim ASA's management efficiency ratios could be used to measure how well Medistim ASA manages its routine affairs as well as how well it operates its assets and liabilities.Medistim ASA Workforce Comparison
Medistim ASA is rated below average in number of employees category among its peers. The total workforce of Medical Devices industry is now estimated at about 25,366. Medistim ASA adds roughly 116 in number of employees claiming only tiny portion of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27. Medistim ASA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Medistim ASA Price Series Summation is a cross summation of Medistim ASA price series and its benchmark/peer.
Medistim ASA Notable Stakeholders
A Medistim ASA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medistim ASA often face trade-offs trying to please all of them. Medistim ASA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medistim ASA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas Jakobsen | Chief Officer | Profile | |
| Ole Robsrud | CEO AS | Profile | |
| Hakon Grothe | Chief Officer | Profile | |
| Roger Morberg | VP Sales | Profile | |
| Kari Krogstad | CEO Pres | Profile | |
| Helge Borslid | VP Manufacturing | Profile | |
| Mike Farbelow | Pres Inc | Profile | |
| Cindy Kaffai | Country GmbH | Profile | |
| Hge Wetterhus | VP Marketing | Profile | |
| Ole Eiksund | Chief Officer | Profile |
About Medistim ASA Management Performance
The success or failure of an entity such as Medistim ASA often depends on how effective the management is. Medistim ASA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medistim management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medistim management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway. MEDISTIM ASA operates under Medical Equipment classification in Norway and is traded on Oslo Stock Exchange. It employs 105 people.
Medistim ASA Workforce Analysis
Traditionally, organizations such as Medistim ASA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medistim ASA within its industry.Medistim ASA Manpower Efficiency
Return on Medistim ASA Manpower
| Revenue Per Employee | 3.6M | |
| Revenue Per Executive | 41.8M | |
| Net Income Per Employee | 783.6K | |
| Net Income Per Executive | 9.1M | |
| Working Capital Per Employee | 801.7K | |
| Working Capital Per Executive | 9.3M |
Other Information on Investing in Medistim Stock
Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.